Anticorps Polyclonal de lapin anti-HABP4

HABP4 Polyclonal Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 33317-1-PBS

Synonymes

Hyaluronan-binding protein 4, IHABP4, IHABP-4, Intracellular hyaluronan-binding protein 4, Ki-1/57 intracellular antigen

---

Galerie de données de validation

• 

  WB analysis using 33317-1-AP (same clone as 33317-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 33317-1-AP (HABP4 antibody) at dilution of 1:4000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 33317-1-PBS in a different storage buffer formulation.

---

Informations sur le produit

33317-1-PBS cible HABP4 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: HABP4 Protéine recombinante Ag39922
• Nom complet: hyaluronan binding protein 4
• Masse moléculaire calculée: 46kDa，413aa
• Poids moléculaire observé: 57 kDa
• Numéro d’acquisition GenBank: NM_014282.3
• Symbole du gène: HABP4
• Identification du gène (NCBI): 22927
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

HABP4 (hyaluronic acid binding protein 4) is an intracellular regulatory protein, with a molecular weight of about 57 kDa (PMID: 33245729), which is rich in positively charged amino acids and can bind with negatively charged macromolecules such as RNA and hyaluronic acid. It has SUMO binding activity, participates in PML tissue, negatively regulates DNA binding activity, and positively regulates gene expression. In addition, HABP4 has a complex interaction network in cells, and has undergone a variety of post-translational modifications, including serine/threonine phosphorylation, arginine methylation and SUMO.

{{ptg:RelatedPrimaryAntibodies}}